i understand everyone's view point, but I refuse to believe that in 2019 with less cash on hand, no product we were already at 0.28 vs today a product already for sale in Japan and ready for commercialization with a sales channel ready to be literally switched on that we can't exceed prior ATH on FDA approval because it's "priced in"
Sorry ya'll but those expecting a lack luster day of trading on FDA approval aren't thinking right
Not even a FUD thing at this stage - logically I cannot comprehend prior market sentiment with f* all in hand vs today... it's not mathing for me bruh
Ann: Final Sofdra Labelling Discussions with FDA, page-56
-
- There are more pages in this discussion • 227 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.030(9.68%) |
Mkt cap ! $615.4M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 34.3¢ | 30.8¢ | $3.843M | 11.64M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 106766 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 353068 | 6 |
View Market Depth
| Last trade - 16.10pm 06/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |